ABSTRACT
This chapter discusses some public views on the genomic knowledge claims around personalized medicine, in the context of wider developments in new genetics and in relation to issues of accountability and trust. It aims to unpack and critically analyze some of the claims made and shared by participants over issues of procedure within science and genetics. The chapter has argued that while pharmacogenetics is finding clinical applications in an increasingly large number of medical fields, including psychiatry, research into public views over personalized medicine is still relatively scarce. The work conducted in the UK often overemphasizes the promises of pharmacogenetics, and rarely contextualizes this technology either in terms of the general allocation of healthcare resources, in a national health service such as the NHS, or in terms of commercialization of tests and information over the counter or on the internet.
